Hydrocephalus Complicating Intrathecal Antisense Oligonucleotide Therapy for Huntington's Disease. (2021)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/mds.28359
PubMed Identifier: 33125799
Publication URI: http://europepmc.org/abstract/MED/33125799
Type: Journal Article/Review
Volume: 36
Parent Publication: Movement disorders : official journal of the Movement Disorder Society
Issue: 1
ISSN: 0885-3185